William Raj Sellers, M.D.

Novartis, Basel, Basel-Stadt, France 
 Dana-Farber Cancer Institute and Harvard Medical School, USA 
 Broad Institute - Cancer Program 
"William Sellers"
Mean distance: 19.98 (cluster 51)
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Cantor SB, Sellers WR, Pathania S, et al. (2022) David Livingston (1941-2021). Molecular Cell. 82: 4-7
Ito T, Young MJ, Li R, et al. (2021) Paralog knockout profiling identifies DUSP4 and DUSP6 as a digenic dependence in MAPK pathway-driven cancers. Nature Genetics
LaMarche MJ, Acker MG, Argintaru A, et al. (2020) Identification of TNO155, an Allosteric SHP2 Inhibitor for the Treatment of Cancer. Journal of Medicinal Chemistry
Palmer AC, Plana D, Gao H, et al. (2020) A proof of concept for biomarker-guided targeted therapy against ovarian cancer based on patient-derived tumor xenografts. Cancer Research
Nusinow DP, Szpyt J, Ghandi M, et al. (2020) Quantitative Proteomics of the Cancer Cell Line Encyclopedia. Cell. 180: 387-402.e16
Cleary JM, Raghavan S, Li YY, et al. (2020) Therapeutic targeting of extracellular FGFR2 activating deletions in intrahepatic cholangiocarcinoma. Journal of Clinical Oncology. 38: 567-567
Wernitznig A, Lipp JJ, Zichner T, et al. (2020) Abstract 3227: CLIFF, a bioinformatics software tool to explore molecular differences between two sets of cancer cell lines Cancer Research. 80: 3227-3227
Weiss A, Stauffer F, Clemens C, et al. (2020) Abstract 1770: A new DOT1L inhibitor with in vivo activity in mouse models of MLL-translocated leukemia Cancer Research. 80: 1770-1770
Li YY, Cleary JM, Raghavan S, et al. (2020) Abstract 1097: FGFR2 in-frame indels: A novel targetable alteration in intrahepatic cholangiocarcinoma Tumor Biology
Li H, Bullock K, Gurjao C, et al. (2019) Metabolomic adaptations and correlates of survival to immune checkpoint blockade. Nature Communications. 10: 4346
See more...